QLI Qilian International Holding Group: Market Capitalization to Book Value Ratio

Official company branding of Qilian International Holding Group Limited (QLI)

The production of basic chemical components and traditional medicine products ensures a stable income for Qilian International (QLI). After analyzing the market cap-to-book ratio on GURU.Markets, we find that the indicator remains around 4.55. Qilian International (QLI) relies on logistics diversification to protect margins from trade wars, while robotic lines in China guarantee minimum production costs for finished pharmaceuticals.

Qilian International (QLI) - Market Capitalization to Book Value Ratio from 07/04/2022 to 08/17/2024

QLI (Qilian International Holding Group): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart Qilian International|QLI - Forecast Levels Chart
- market capitalization data:
Market Capitalization Qilian International Holding Group Limited|QLI - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share Qilian International|QLI - Book Capitalization|Market Value to Book Value Ratio qlsyy.net|QLI - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Qilian International|QLI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Qilian International Holding Group Limited|QLI - Company Aggregate Debts|Debt to Book Value Qilian International Holding Group Limited|QLI - Company Long-Term Loans and Borrowings|Company Short-Term Debt Qilian International
Basic company analysis:QLI (Qilian International)
Finished products of Qilian International Holding Group

This indicator compares the current market value of the business with its actual net assets. A decline in the market-to-book value ratio signals a potential undervaluation of Qilian International (QLI). The opaque management of Qilian International (QLI) amplifies this discount, creating a gap between intrinsic value and market quotes. Monitoring the lower bounds of this metric helps determine the margin of safety for investments, which protects capital from unjustified risks during investment.

Direct competitors

Market Value to Book Value Ratio Haleon plc (HLN)|kenvue.com (KVUE) - Market Capitalization to Net Assets|VRNA - Market Capitalization to Book Value Ratio|Market Value to Book Value Jyong Biotech Limited|Market Capitalization to Book Value Ratio LGND|Market Capitalization to Book Value Ratio AMRX (Amneal Corp)|Market Value to Book Value Ratio Perrigo Company plc|alvotech.com - Market Value to Book Value|LQDA: Market Value to Book Value Ratio|GLPG - Market Cap to Net Assets Ratio|ANIP: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Afrezza|AMPH - Market Cap to Net Assets Ratio|Market Value to Book Value PCRX|ARS Pharmaceuticals, Inc. - Market Value to Book Value Ratio|Market-to-Book Ratio Theravance Biopharma Inc TBPH|Market Cap to Net Assets Ratio Aquestive Pharma (AQST)|Market Cap to Book Value Multiple scPharmaceuticals, Inc. SCPH|Market Capitalization to Book Value Ratio Tectonic (TECX)|TNXP - Market Value to Book Value|Market Capitalization to Book Value Ratio SXTC|EPRX (Eupraxia Pharmaceuticals Inc.) - Market-to-Book Ratio|BHST - Market Value to Book Value Ratio|Market Value to Book Value EXOZ|ORMP: Market Value to Book Value Ratio|Market Value to Equity Ratio enterabio.com (ENTX)|Market Capitalization to Book Value Ratio HYFT|ABVC BioPharma Inc. - Market Capitalization to Book Value|CPIX - Market Value to Book Value Ratio|QNTM - Market Value to Book Value Ratio|FibroGen, Inc. - Market Capitalization to Book Value Ratio|telomirpharma.com (TELO) - Market Capitalization to Book Value|RANI (Rani Therapeutics Holdings) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio SNYR|Market Value to Book Value Ratio Rallybio Corporation RLYB|Capitalization to Book Value Ratio lexariabioscience.com LEXX|Market Cap to Net Assets Ratio Pulmatrix, Inc.|Market Value to Book Value Pheton Holdings Limited PTHL|Market Capitalization to Book Value Ratio APM (Aptorum)|LYRA: Market Capitalization to Book Value|Market Value to Book Value Ratio Impact BioMedical|Capitalization to Book Value Ratio TNF Pharmaceuticals, Inc.|cbdMD Inc. (YCBD) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple painreform.com|Altamira Therapeutics - Market Capitalization to Book Value Ratio|Market-to-Book Ratio LIPO (Lipella Pharmaceuticals Inc)|Market Value to Book Value Ratio Optinose|Pieris Pharma - Market Value to Book Value|Procaps Group S.A. (PROC) - Market Value to Book Value Ratio|PTPI - Capitalization to Book Value Ratio|SLRN: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio TFF Pharmaceuticals Inc.